Skip to content Skip to sidebar Skip to footer

Newsletter

International Stocks

QBE Insurance Group (ASX:QBE): Is this the 4-decade long Sydney Swans sponsor the ASX insurer to buy?

If you're a fan of sport, you'd know that QBE Insurance Group (ASX:QBE) have been a sponsor of the Sydney Swans for over 40 years - one of the longest-running sponsorships in global sport. One not knowing anything else about the company would have to assume it must be doing something right to survive as long…

ByNick SundichJanuary 15, 2026

Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$180bn company behind obesity drug Ozempic

Not many 100-year old healthcare stocks see a sudden 30% jump in sales in one year and become the largest capitalised company on their entire continent but Novo Nordisk (CPH: NOVO-B) is one such stock that did just that. Its a Danish drug maker that is behind weight loss drugs Ozempic and Wegovy. For much of…

ByNick SundichJanuary 8, 2026

Stocks Down Under’s Top 10 Hottest ASX Stocks to Look At in 2026!

Today, on the first trading day of 2026, Stocks Down Under publishes its its 10 Hottest ASX Stocks to Look At in the year ahead! What are the Best ASX Stocks to invest in right now? Check our buy/sell tips [sg_popup id="23914" event="click"][/sg_popup] Stocks Down Under's Top 10 Hottest ASX Stocks to Look At in 2026! Note: These…

ByNick SundichJanuary 2, 2026

Our 5 ASX Predictions for 2026!

This article outlines 5 ASX Predictions for 2026 that Stocks Down Under puts its neck on the line to assert will happen. It has become an annual tradition of ours, and some of these calls we get right, others we don't. Arguably our boldest call in suggesting ANZ would be the best performing big 4…

ByNick SundichDecember 24, 2025

Channel Infrastructure NZ (ASX:CHI): Another Kiwi company just joined the ASX, but this one is the nation’s largest fuel supplier

Last Friday, Channel Infrastructure NZ listed on the ASX as a dual-listing. It is unlike the bulk of Kiwi companies that have listed on the ASX before it in being capped at over NZ$1bn and specialising in fuel transportation and supply. And while the New Zealand economy is in a bad shape, this has not…

ByNick SundichDecember 22, 2025

Brambles (ASX: BXB): Withstanding The Impacts of Trump’s Tariffs (For Now)

Brambles (ASX: BXB) has significantly outperformed the ASX 200 in the past year, gaining nearly 20% even with the drop during the furore over Trump's tariffs. As a company worth over $30bn that operates across approximately 60 countries worldwide, with its business heavily tied to global trade flows, it is sensitive to tariffs and geopolitical changes…

ByUjjwal MaheshwariDecember 17, 2025

What does the Fed rate cut mean for Australia? Will it make a difference whether or not the RBA follows suit in 2026?

Many investors will be asking themselves this question: 'What does the Fed rate cut mean for Australia?' This question is always asked, but the answer is a lot less concrete than it would ordinarily be, not least because Australia's RBA will not follow suit, and may even go in a different direction. What are the Best…

ByNick SundichDecember 11, 2025

Sherwin Williams (NYSE:SHW): Who said nothing good comes out of Cleveland? All it gave us was a US$83bn paint giant

Sherwin Williams (NYSE:SHW) is a near 160-year-old paint company from Cleveland, Ohio capped at over US$85bn. This company is one we've been watching for a while but think now is a good time to consider it. Theoretically, a paint company should only be growing at GDP. But it has managed to deliver a heck of a lot…

ByNick SundichOctober 30, 2025

Colgate (NYSE:CL): There’s more to it than toothpaste – it could be the best way to profit from the growth in pet products!

In Australia, we know Colgate (NYSE:CL) primarily as a toothpaste brand. But there's a lot more to this 217-year old company than you may think. We think this stock may be the best way to gain exposure to the growth in pet care. However, we cannot talk about this company without addressing its decline in the past…

ByNick SundichOctober 28, 2025

Vertex Pharmaceuticals (NDQ:VRTX): Another >US$100bn biotech that is facing the cliff like its peers, but might be safer

$100bn biotechs like Vertex Pharmaceuticals (NDQ:VRTX) typically get to their position through 'blockbuster drugs' with periods of market exclusivity, which eventually come to an end and cause revenues to fall as cheaper biosimilars come onto the market. The average biotech is facing a loss of revenue of 38%. Of course, some are higher (i.e. Amgen…

ByNick SundichOctober 23, 2025

the Kick-ass Multipurpose WordPress Theme

International Stocks

QBE Insurance Group (ASX:QBE): Is this the 4-decade long Sydney Swans sponsor the ASX insurer to buy?

Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$180bn company behind obesity drug Ozempic

Stocks Down Under’s Top 10 Hottest ASX Stocks to Look At in 2026!

Our 5 ASX Predictions for 2026!

Channel Infrastructure NZ (ASX:CHI): Another Kiwi company just joined the ASX, but this one is the nation’s largest fuel supplier

Brambles (ASX: BXB): Withstanding The Impacts of Trump’s Tariffs (For Now)

What does the Fed rate cut mean for Australia? Will it make a difference whether or not the RBA follows suit in 2026?

Sherwin Williams (NYSE:SHW): Who said nothing good comes out of Cleveland? All it gave us was a US$83bn paint giant

Colgate (NYSE:CL): There’s more to it than toothpaste – it could be the best way to profit from the growth in pet products!

Vertex Pharmaceuticals (NDQ:VRTX): Another >US$100bn biotech that is facing the cliff like its peers, but might be safer

Sectors

Quick Links

Learn

2020, the Golden Year

Investing in the Year of the Rat

Market trouble spots to avoid in 2020

International Stocks

Sectors

Quick Links

Learn

Add Your Heading Text Here